PEPFAR: PEPFAR and DREAMS Partners Announce Winners of the $85 Million DREAMS Innovation Challenge
“[Monday], the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR); Janssen Pharmaceutica NV (Janssen), one of the Janssen pharmaceutical companies of Johnson & Johnson; and ViiV Healthcare announced a combined $85 million investment to support 56 DREAMS Innovation Challenge [provisional] winners in 10 sub-Saharan African countries. Of this investment, $40 million is focused on keeping girls in secondary school, which dramatically reduces their vulnerability to HIV infection, and nearly half of these education-focused resources are directed to Malawi…” (7/18).